TCP1 and cancer: CCT1, CCT5, and FKBP4 showed significantly lower expression in the cancer patients compared to the healthy volunteers, whereas HSPA9 and TRAP1 showed a significantly higher expression in patients with cancer compared to the control group for the most cancer types.